United States · Platforms & data · MarketBeat

What United States Antimony (UAMY) Said on Its Q3 Earnings Call

Published by MarketBeat · United States 32 min ago

Image from MarketBeat Media, LLC. · MarketBeat

Detailed summary

United States Antimony (NYSE:UAMY) reported higher third-quarter revenue and a wider gross margin as increased sales volumes helped offset declining antimony prices, but the company posted a net loss amid exploration spending and a noncash investment loss. The company also replaced its revenue guid

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Fortress Biotech GAAP EPS of -$0.23 beats by $0.04, revenue of $19.16M misses by $2.41M

The Motley Fool

Novo Nordisk Seeks FDA, EMA Approval For Sickle Cell Disease Treatment – Here Are The Key Takeaways

TheStreet

What United States Antimony (UAMY) Said on Its Q3 Earnings Call

Detailed summary

Share

Also worth reading

Fortress Biotech GAAP EPS of -$0.23 beats by $0.04, revenue of $19.16M misses by $2.41M

How Much Is Nvidia Stock Worth Without Jensen Huang?

The science of vaccines is rapidly advancing — despite the anti-vax movement

Stifel cuts EyePoint stock price target on trial setbacks

Novo Nordisk Seeks FDA, EMA Approval For Sickle Cell Disease Treatment – Here Are The Key Takeaways

If you invested $1,000 in XRP the day Ripple beat SEC, here’s what it’s worth now